29 May 2024
International Market Update and Health Canada approvals
● Following January 2024 launch into health retail in the UK and Ireland, Biome
expects FY24 International sales revenue to surpass $850k
● Biome expects FY24 international sales revenue to grow 85%+ vs PCP (FY23 $459k)
● Biome secures approval from Health Canada for eight product registrations, with
more to follow in Q4 FY24
● Biome commences exploration into Western European markets for FY25 expansion
● Biome expects a test market launch into North America via Canada in H2 FY25
Great announcement
- We are now active in Australia/UK/Ireland
- Soon to be selling in Canada with approvals being secured
- A pathway to the US market has been identified for test launch
One suspects we will hear more about expansion into Europe in due course - being a logical extension from the UK market
Biome going from strength to strength - great work to Blair and the team
- Forums
- ASX - By Stock
- Ann: International Market Update and Health Canada approvals
29 May 2024International Market Update and Health Canada...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIO (ASX) to my watchlist
(20min delay)
|
|||||
Last
61.0¢ |
Change
-0.035(5.43%) |
Mkt cap ! $133.6M |
Open | High | Low | Value | Volume |
64.0¢ | 65.0¢ | 61.0¢ | $304.0K | 488.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 65679 | 61.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
61.5¢ | 4100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 65679 | 0.610 |
5 | 27011 | 0.605 |
12 | 120025 | 0.600 |
1 | 8386 | 0.595 |
2 | 15364 | 0.590 |
Price($) | Vol. | No. |
---|---|---|
0.615 | 4100 | 1 |
0.620 | 3644 | 1 |
0.625 | 22882 | 2 |
0.630 | 45087 | 3 |
0.640 | 4500 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BIO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online